What are antimicrobial peptides?
Antimicrobial peptides are protein molecules of the innate immune system and are found in all organisms. They have potent broad-spectrum antimicrobial properties and help protect the body against infection.
There are over 100 antimicrobial peptides in the skin. The best characterised are:
Cathelicidins were the first AMPs discovered and are abundantly expressed in mast cells. The only human cathelicidin is LL-37 and is also known as cathelicidin antimicrobial peptide 18 kDa or CAP-18.
α-Defensins and β-defensins are widely distributed in epithelial cells and phagocytes in high concentrations.
Where are antimicrobial peptides found?
Antimicrobial peptides are found in a variety of tissues throughout the body. In the skin, antimicrobial peptides are mainly produced by:
- Sweat glands.
They are stored in lamellar bodies (secretory granules found within the layers of cells in the skin). Circulating immune cells, particularly neutrophils, also produce antimicrobial peptides.
- Antimicrobial peptide production is induced by growth factors and circulating immune cells.
- Some antimicrobial peptides are resident in normal, healthy skin.
- The amount of a particular antimicrobial peptide varies with the level of protection required. For example, higher concentrations of the antimicrobial peptide, psoriasin (also known as S100 calcium-binding protein A7 or S100A7), are found on the hands, feet, armpits, and scalp.
- Other antimicrobial peptides (eg, LL-37) are triggered into action by cutaneous injury, infection or inflammation.
What is the function of antimicrobial peptides?
Functions of antimicrobial peptides include:
- Antimicrobial action — antibacterial (fighting Gram-positive and Gram-negative bacteria), antiviral and antifungal action
- Immunomodulatory effects — the recruitment of immune cells to sites of infection or injury
- Wound healing — the formation of new blood vessels and skin at sites of injury
- Cell apoptosis — killing pathogens
- Anticancer activity.
What is the role of antimicrobial peptides in atopic eczema?
Patients with atopic dermatitis (eczema) have decreased levels of antimicrobial peptides in their skin. Patients with atopic dermatitis are susceptible to:
- Recurrent bacterial skin infections and colonisation with Staphylococcus aureus
- Viral skin infections, such as herpes simplex and molluscum contagiosum.
What is the role of antimicrobial peptides in psoriasis?
There are increased levels of antimicrobial peptides in psoriasis plaques.
- Bacterial infection is uncommon in psoriasis, despite significant barrier disruption.
- Antimicrobial peptides, such as β-defensin 2, may have a role in the pathogenesis of psoriasis. They are thought to form complexes with self-DNA, activating the immune system and causing inflammation.
- Sunlight induces antimicrobial peptides in the skin via the vitamin D pathway. This may contribute to an improvement in psoriasis in summer.
What is the role of antimicrobial peptides in rosacea?
Rosacea is characterised by inflammation and vascular reactivity.
- The cathelicidin LL-37 is usually broken down into small peptides with more antimicrobial and less inflammatory effects.
- In rosacea, abnormal processing leads to higher levels of LL-37 and subsequent inflammation.
What is the therapeutic potential of antimicrobial peptides?
Understanding the molecular elements of antimicrobial peptides might lead to better understanding of inflammatory skin disease and new treatments.
New antimicrobial agents
- Have broad spectrum and selective antibacterial, antiviral and antifungal activity
- Are non-toxic to host cells
- Are highly conserved (ie, antimicrobial peptide genes are found in multiple animal and plant species through geological time).
- Vitamin D3 and enhanced antimicrobial peptide production on exposure to ultraviolet radiation could reduce infection and restore barrier function in atopic dermatitis.
- Blocking abnormal antimicrobial peptide formation and/or processing could lead to novel treatments for rosacea.
- Inhibiting antimicrobial peptide complex formation could reduce immune activation in psoriasis.
Treatment of inflammatory skin diseases
The anticancer properties of antimicrobial peptides are currently not well characterised, but there is speculation that antimicrobial peptides could lead to new treatments in the future.